These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7849428)
1. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis]. Bresgen M; Baum U; Esser P; Wiedemann P; Heimann K Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428 [TBL] [Abstract][Full Text] [Related]
2. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases]. Clausen R; Weller M; Hilgers RD; Heimann K; Wiedemann P Fortschr Ophthalmol; 1990; 87(3):283-6. PubMed ID: 2376377 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification]. Bresgen M; Martiny B; Weller M; Heimann K; Wiedemann P Fortschr Ophthalmol; 1991; 88(6):665-70. PubMed ID: 1794787 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of RAGE and its ligands in proliferative retinal disease. Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280 [TBL] [Abstract][Full Text] [Related]
6. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Capeans C; De Rojas MV; Lojo S; Salorio MS Retina; 1998; 18(6):546-50. PubMed ID: 9869464 [TBL] [Abstract][Full Text] [Related]
7. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy. Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767 [TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy. Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657 [TBL] [Abstract][Full Text] [Related]
11. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635 [TBL] [Abstract][Full Text] [Related]
12. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate-polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry. Mukai N; Nakanishi T; Shimizu A; Takubo T; Ikeda T Ann Clin Biochem; 2008 May; 45(Pt 3):307-12. PubMed ID: 18482920 [TBL] [Abstract][Full Text] [Related]
13. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier]. Grisanti S; Wiedemann P; Heimann K Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633 [TBL] [Abstract][Full Text] [Related]
14. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [TBL] [Abstract][Full Text] [Related]
15. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study. Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318 [TBL] [Abstract][Full Text] [Related]
16. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819 [TBL] [Abstract][Full Text] [Related]
17. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy]. Adamiec J; Oficjalska-Młyńczak J Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. Gao BB; Chen X; Timothy N; Aiello LP; Feener EP J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156 [TBL] [Abstract][Full Text] [Related]
19. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700 [TBL] [Abstract][Full Text] [Related]
20. Identification and localization of major soluble vitreous proteins in human ocular tissue. Wu CW; Sauter JL; Johnson PK; Chen CD; Olsen TW Am J Ophthalmol; 2004 Apr; 137(4):655-61. PubMed ID: 15059704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]